NCT02545556View on ClinicalTrials.gov

Liver Cancer HepaSphere Combined With Cryosurgery

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Liver Cancer
Interventions
PROCEDURE

HepaSphere combined with cryosurgery

liver cancer patients received HepaSphere interventional therapy using the digital subtraction angiography（DSA）combined with cryosurgery

Trial Locations (1)

510000

Central laboratory in Fuda cancer hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02545556 - Liver Cancer HepaSphere Combined With Cryosurgery | Biotech Hunter | Biotech Hunter